Cell therapy is emerging as a promising cancer treatment of
last resort. KTH researcher Björn Önfelt and his team in SciLifeLab are working
to identify and strengthen cells that can counter the disease.
“We are developing methods so that, on a single-cell level,
we can study how immune cells interact with other cells to predict the outcome
of stem cell transplantation, and develop cells that could be used to kill
tumours in cell therapy,” says Önfelt, whose research just received SEK 32
million (EUR 3.5 million) over five years from the Swedish Foundation for
Strategic Research, in the field of medical technology.